Top compounds associated with response to APRT


Feature Type Standardized
Nominal ANOVA
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.002
mRNA Midostaurin GDSC1000 pan-cancer AAC 0.1 0.003
mRNA JNK-9L GDSC1000 pan-cancer AAC 0.11 0.003
mRNA Nutlin-3a (-) GDSC1000 pan-cancer AAC 0.1 0.003
mRNA RDEA119 GDSC1000 pan-cancer AAC 0.091 0.003
mRNA GW-2580 GDSC1000 pan-cancer AAC -0.1 0.003
mRNA CHIR-99021 GDSC1000 pan-cancer AAC 0.092 0.004
mRNA BRD9876 CTRPv2 pan-cancer AAC 0.11 0.005
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.094 0.005
mRNA Vandetanib CTRPv2 pan-cancer AAC 0.1 0.005
Download CSV